Herts and Essex Fertility - IVF Spot Purchase NCL ICB

NHS North Central London ICB has awarded a contract titled "Herts and Essex Fertility - IVF Spot Purchase NCL ICB" for in vitro fertilisation services under the Health Care Services (Provider Selection Regime) Regulations 2023. This contract was awarded through a limited procurement method without prior publication of a call for competition and falls outside the scope of the directive under the Public Contracts Regulations 2015. The contract was signed on 25th March 2025.

The buying organisation, with contact based in London, focuses on developing services for CYP, CAMHS, Maternity, and Neonates under Patient Choice. The primary delivery location for this service is in the UKH2 region, specifically Cheshunt, England. This tender presents significant opportunities for businesses in the healthcare sector, especially those offering in vitro fertilisation services.

It is particularly relevant for SMEs like the awarded supplier, Herts and Essex Fertility Centre Limited, which can leverage this contract to enhance their market presence and service portfolio. Businesses specialising in fertility treatments and those looking to expand into niche healthcare services stand to benefit from participating in similar procurements. The focus on direct patient choice and the streamlined procurement process under the new regime opens avenues for agile and specialised providers to secure contracts with health care commissioners.